Compare SWK Holdings Corp. with Similar Stocks
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
7.19%
0%
7.19%
6 Months
17.05%
0%
17.05%
1 Year
5.1%
0%
5.1%
2 Years
2.25%
0%
2.25%
3 Years
-10.13%
0%
-10.13%
4 Years
-7.63%
0%
-7.63%
5 Years
22.0%
0%
22.0%
SWK Holdings Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
7.83%
EBIT Growth (5y)
45.80%
EBIT to Interest (avg)
16.90
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
24.51%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
88.21%
ROCE (avg)
10.15%
ROE (avg)
7.11%
Valuation key factors
Factor
Value
P/E Ratio
9
Industry P/E
Price to Book Value
0.60
EV to EBIT
4.21
EV to EBITDA
4.06
EV to Capital Employed
0.55
EV to Sales
3.07
PEG Ratio
0.25
Dividend Yield
0.03%
ROCE (Latest)
13.13%
ROE (Latest)
6.48%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 14 Schemes (4.75%)
Foreign Institutions
Held by 15 Foreign Institutions (0.39%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
10.10
11.70
-13.68%
Operating Profit (PBDIT) excl Other Income
7.00
5.30
32.08%
Interest
1.20
1.10
9.09%
Exceptional Items
0.00
0.00
Consolidate Net Profit
3.50
4.50
-22.22%
Operating Profit Margin (Excl OI)
611.40%
565.70%
4.57%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is -13.68% vs -10.69% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is -22.22% vs -23.73% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
46.20
37.00
24.86%
Operating Profit (PBDIT) excl Other Income
37.90
22.60
67.70%
Interest
4.70
1.80
161.11%
Exceptional Items
-0.90
-2.10
57.14%
Consolidate Net Profit
13.50
15.90
-15.09%
Operating Profit Margin (Excl OI)
503.70%
480.20%
2.35%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 24.86% vs -10.41% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -15.09% vs 17.78% in Dec 2023
About SWK Holdings Corp. 
SWK Holdings Corp.
Finance
SWK Holdings Corporation is a healthcare capital provider. The Company offers financing solutions to a range of life science companies, institutions and inventors. The Company comprises of two segments Finance Receivables and Pharmaceutical Development. The Company's focus is on monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. The Company, through its subsidiary SWK Advisors LLC, provides non-discretionary investment advisory services to institutional clients in separately managed accounts to similarly invest in life science finance. It focuses to fund transactions through its own working capital, as well as by building its asset management business by raising additional third party capital to be invested alongside its capital.
Company Coordinates 
Company Details
14755 Preston Rd Ste 105 , DALLAS TX : 75254-6815
Registrar Details






